Alexion in Europe

Alexion established operations in Europe in 2005 to support the introduction of our first treatment. Several key global and regional functions for Alexion are now based in Europe. This includes our International headquarters in Zürich, Switzerland, which serves as the backbone of the Company’s International country operations (all markets ex-U.S. and Japan) and supports our mission to serve a growing number of patients with severe and life-threatening disorders. Our global supply chain, quality and manufacturing operations are based in Ireland. Alexion is serving patients with life-threatening rare diseases across Europe and in more than 50 countries internationally.

International Headquarters

Alexion Pharma GmbH

Giesshübelstrasse 30
8045 Zürich, Switzerland
Ph: +41 44 457 40 00 
Fax: +41 44 457 40 01 


Global Supply Chain and Operations, Ireland

Since 2013, Alexion’s facility in Blanchardstown, Dublin has served as the Company’s Global Supply Chain and Operations headquarters. The site, which will be home to a large-scale biologics manufacturing facility, is also used to house packaging and testing operations in support of our Global Manufacturing network. Construction of a second biologics manufacturing facility in Athlone, Ireland has also begun, and this will accompany the location’s existing fill-finish facility.

Alexion’s investments in both Athlone and Blanchardstown have created a significant number of local job opportunities, including construction jobs, while the sites are being developed as well as full-time Alexion positions. As we continue to drive forward our mission of serving patients with rare diseases, the expansion of our Irish facilities will be at the forefront of this vital work globally.

Our Quality team based in Ireland.